![Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes - Research and Practice in Thrombosis and Haemostasis Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/asset/344c2629-4eeb-45fa-b841-5f84bf98bd37/rth212604-fig-0001-m.jpg)
Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes - Research and Practice in Thrombosis and Haemostasis
![The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis - Mouhand F. H. Mohamed, Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis - Mouhand F. H. Mohamed, Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina](https://journals.sagepub.com/cms/10.1177/1076029620940046/asset/images/large/10.1177_1076029620940046-fig2.jpeg)
The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis - Mouhand F. H. Mohamed, Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina
![PDF) XALIA: Rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis PDF) XALIA: Rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis](https://i1.rgstatic.net/publication/264501177_XALIA_Rationale_and_design_of_a_non-interventional_study_of_rivaroxaban_compared_with_standard_therapy_for_initial_and_long-term_anticoagulation_in_deep_vein_thrombosis/links/53efbab50cf23733e812d7e3/largepreview.png)
PDF) XALIA: Rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis
Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for
![Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study - ScienceDirect Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952922002440-grabsf1.jpg)
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study - ScienceDirect
![CLIN D'OEIL, καθρέφτη τσέπη, μασίφ οξιά, το γυαλί και το μαλλί των προβάτων, τον οικολογικό σχεδιασμό CLIN D'OEIL, καθρέφτη τσέπη, μασίφ οξιά, το γυαλί και το μαλλί των προβάτων, τον οικολογικό σχεδιασμό](https://www.my-deco-shop.com/1374-33090-thickbox/clin-d-oeil-pocket-mirror-solid-beech-glass-sheep-wool-eco-design.jpg)
CLIN D'OEIL, καθρέφτη τσέπη, μασίφ οξιά, το γυαλί και το μαλλί των προβάτων, τον οικολογικό σχεδιασμό
Safety and effectiveness of rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis in
![Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study - The Lancet Haematology Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study - The Lancet Haematology](https://www.thelancet.com/cms/attachment/2042973808/2055635024/gr1.gif)
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study - The Lancet Haematology
![A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts Prof. - ppt download A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts Prof. - ppt download](https://slideplayer.com/79/13076206/big_thumb.jpg)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts Prof. - ppt download
![Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3a1819d84aae621048b39b1dd2a68219800faf2/7-Table3-1.png)